ELK1 and head and neck squamous cell carcinoma: Elevated PLXDC2 expression in radioresistant HNSCC cells is mediated by c-Met-ERK1/2 activation, which phosphorylates the downstream effector ELK1, promoting it to translocate into the nucleus and bind to the PLXDC2 gene promoter to initiate the gene transcription.